NEW: The Biden administration proposal to allow Medicare and require Medicaid to cover drugs used to treat obesity could expand access to costly GLP-1 drugs for millions of people with obesity while increasing federal and state costs. @kff.org's experts explain: www.kff.org/policy-watch...